Literature DB >> 16198223

Adherence beliefs among breast cancer patients taking tamoxifen.

Elizabeth A Grunfeld1, Myra S Hunter, Pooja Sikka, Sangeeta Mittal.   

Abstract

Information about the reasons for non-adherence among breast cancer patients taking tamoxifen is essential for the development of interventions that may increase adherence. The present study investigated treatment experiences and perceptions among women taking tamoxifen and how these related to adherence behaviour. Hundred and ten women completed questionnaires including the Women's Health Questionnaire, Hot Flushes and Night Sweats Questionnaire, Beliefs about Medicine Questionnaire and a self-report measure of adherence. Non-adherers were more likely to report a belief that there was nothing to be gained from taking tamoxifen whereas adherers were more likely to report that tamoxifen would stop them from developing breast cancer. The main reason for not taking tamoxifen was reported to be side effects. There were no differences between adherers with regard to the strategies used to remember to take tamoxifen or with regard to the time of day tamoxifen was taken. The results have implications for the role of health professionals in informing patients of the purpose of their treatment and for the development of symptom-management interventions for this patient group.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198223     DOI: 10.1016/j.pec.2004.10.005

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  76 in total

1.  Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women.

Authors:  Kathryn E Weaver; Fabian Camacho; Wenke Hwang; Roger Anderson; Gretchen Kimmick
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

2.  Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer.

Authors:  Shoshana M Rosenberg; Annette L Stanton; Keith J Petrie; Ann H Partridge
Journal:  Oncologist       Date:  2015-05-01

3.  Adjuvant endocrine therapy in premenopausal women with breast cancer.

Authors:  Kunal C Kadakia; N Lynn Henry
Journal:  Clin Adv Hematol Oncol       Date:  2015-10

4.  Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer.

Authors:  Catherine M Bender; Amanda L Gentry; Adam M Brufsky; Frances E Casillo; Susan M Cohen; Meredith M Dailey; Heidi S Donovan; Jacqueline Dunbar-Jacob; Rachel C Jankowitz; Margaret Q Rosenzweig; Paula R Sherwood; Susan M Sereika
Journal:  Oncol Nurs Forum       Date:  2014-05       Impact factor: 2.172

5.  The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer.

Authors:  Dawn L Hershman; Jennifer Tsui; Jay Meyer; Sherry Glied; Grace Clarke Hillyer; Jason D Wright; Alfred I Neugut
Journal:  J Natl Cancer Inst       Date:  2014-10-27       Impact factor: 13.506

Review 6.  A Systematic Review of Adherence to Oral Antineoplastic Therapies.

Authors:  Joseph A Greer; Nicole Amoyal; Lauren Nisotel; Joel N Fishbein; James MacDonald; Jamie Stagl; Inga Lennes; Jennifer S Temel; Steven A Safren; William F Pirl
Journal:  Oncologist       Date:  2016-02-26

7.  Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.

Authors:  Renée Simon; Jean Latreille; Claire Matte; Pierre Desjardins; Eric Bergeron
Journal:  Can J Surg       Date:  2014-02       Impact factor: 2.089

8.  Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy.

Authors:  S P Krotneva; A Ramjaun; K E Reidel; T Eguale; N Trabulsi; N Mayo; R Tamblyn; A N Meguerditchian
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

Review 9.  Oral antineoplastic agents: how do we care about adherence?

Authors:  Marie Barillet; Virginie Prevost; Florence Joly; Bénédicte Clarisse
Journal:  Br J Clin Pharmacol       Date:  2015-10-28       Impact factor: 4.335

10.  Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.

Authors:  C McCowan; J Shearer; P T Donnan; J A Dewar; M Crilly; A M Thompson; T P Fahey
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.